Biotech vet and ex-Bio­gen ex­ec Tony Kings­ley jumps to a new CEO post

4 years ago
People

De­nali of­fers more clues on clin­i­cal hold, turn­ing over FDA wor­ries on pre­clin­i­cal tox for Alzheimer's drug

4 years ago
FDA+

Mar­ket is­sues prey on po­ten­tial bounce­back for an­tibi­otics, says a new re­port — here's how to fix it

4 years ago
Pharma

Eli Lil­ly and Roche ask CMS not to be lumped in with Aduhelm’s re­stric­tive judg­ment

4 years ago
FDA+

Small pain drug play­er gets snapped up in $604M buy­out — and the axe will soon fall

4 years ago
Deals

As Omi­cron rages, FDA clears Eli Lil­ly/Ab­Celler­a's new an­ti­body days af­ter $720M sup­ply deal

4 years ago
FDA+
Coronavirus

Scoop: Star neu­ro­sci­en­tist Asa Abe­liovich and Or­biMed are team­ing on yet an­oth­er biotech

4 years ago
People
Startups

Mod­er­na in fi­nal talks to build an mR­NA man­u­fac­tur­ing and R&D hub in the UK — re­port

4 years ago
R&D
Manufacturing

Lat­est news on Covid vac­cine de­lay for kids; Door slammed shut for Chi­na-on­ly da­ta; Er­ic Lan­der is out; Look­ing back ...

4 years ago
Weekly

FDA post­pones ad­comm for Pfiz­er's Covid-19 vac­cine for the youngest age group

4 years ago
R&D
Coronavirus

No­vo Nordisk wins over doc­tors with AI email sub­ject lines — and a hu­man touch

4 years ago
Pharma
Marketing

Ap­peals court quash­es Sanofi’s big win on bell­wether hair loss case

4 years ago
Pharma

Fu­ji­film stays hot, launch­es $60M in­vest­ment fund for new deals

4 years ago
Financing
Manufacturing

Trump ad­min­is­tra­tion in­sid­er Brett Giroir is tak­ing the reins at a biotech start­up

4 years ago
People
Pharma

Ge­nomics + ma­chine learn­ing = com­pa­ny's strat­e­gy to speed up hos­pi­tal di­ag­nos­tics and iden­ti­fy an­tibi­ot­ic re­sis­tance

4 years ago
AI
Diagnostics

FTC plots a look in­to the com­pet­i­tive im­pact of PBMs on drug prices, phar­ma­cies

4 years ago
Pharma

EMA ini­ti­ates safe­ty re­view on JAK in­hibitors; Gala­pa­gos woes con­tin­ue as it ter­mi­nates lat­est study 

4 years ago
News Briefing

As it pre­pares to join EQT, Life Sci­ence Part­ners sur­pass­es €1B in­vest­ment mark

4 years ago
Financing

Af­ter Lil­ly's sin­til­imab shel­lack­ing, Chi­na-on­ly on­col­o­gy tri­als are fac­ing a new — and un­fa­vor­able — re­al­i­ty at ...

4 years ago
R&D
China

Hunt­ing more R&D deals, Ipsen is ham­mer­ing out a $460M sale of con­sumer ops while cut­ting costs

4 years ago
Pharma

In lat­est an­ti­sense fail­ure, Pro­QR's rare eye dis­ease treat­ment falls flat

4 years ago
R&D

Rich Hey­man-backed biotech gets out the axe as it sets course on sur­vival mis­sion

4 years ago
R&D

On long hunt for off-the-shelf CAR-T, Cel­lec­tis woos biotech chief to be­come its CFO

4 years ago
People

Covid-19 roundup: US to pay $725M for Eli Lil­ly's new mAb, if au­tho­rized; WHO chief sci­en­tist says more vari­ants are ...

4 years ago
Coronavirus
First page Previous page 575576577578579580581 Next page Last page
A service from the Financial Times